Free tool
Diagnostics stocks
We cover 45 companies grouped under the Diagnostics theme. The median market value in the group is $42.69M. Across the group, the median move over the past trading day is 0.00%. 41% of the 44 with a 200-day average trade above it. Price change over the past year runs from −69.4% to +14.4% across the middle 80 percent of the group, with a median of −18.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
45 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| VOX.WA | Voxel S.A. | $376.42M | Small cap | −18.11% |
| N3B.F | Anbio Biotechnology | $361.87M | Small cap | −83.42% |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% |
| IDHC.L | Integrated Diagnostics Holdings plc | $298.80M | Small cap | +16.89% |
| ALERS.PA | Eurobio Scientific Société anonyme | $232.43M | Small cap | −21.89% |
| S2B.WA | Syn2bio S.A. | $151.66M | Small cap | +76.47% |
| EKF.L | EKF Diagnostics Holdings plc | $145.56M | Small cap | −15.56% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| SCP.WA | Scope Fluidics S.A. | $120.06M | Small cap | −9.90% |
| S84.F | Scope Fluidics S.A. | $118.77M | Small cap | −10.43% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% |
| BIOPOR.CO | BioPorto A/S | $93.40M | Micro cap | −3.13% |
| 7V0.DE | Novogenia AG | $89.54M | Micro cap | −25.00% |
| ALKLH.PA | Klea Holding SA | $54.74M | Micro cap | −32.00% |
| BIOBV.HE | Biohit Oyj | $46.63M | Micro cap | −8.13% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| ALNOV.PA | Novacyt S.A. | $42.69M | Micro cap | +7.38% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| ABDX.L | Abingdon Health Plc | $36.92M | Micro cap | +104.76% |
| ACARIX.ST | Acarix AB (publ) | $32.23M | Micro cap | −14.11% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| NN6.DE | NanoRepro AG | $27.65M | Micro cap | −4.90% |
| ALIKO.PA | Ikonisys S.A. | $26.94M | Micro cap | −6.58% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| ALBIO.PA | Biosynex SA | $19.25M | Micro cap | −23.23% |
| URT.WA | Urteste S.A. | $17.98M | Micro cap | −15.31% |
| GMT.WA | Genomtec S.A. | $17.34M | Micro cap | −40.65% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.67M | Micro cap | −30.12% |
| BOUL.ST | Boule Diagnostics AB (publ) | $12.76M | Micro cap | −47.36% |
| BMX.WA | BioMaxima S.A. | $11.52M | Micro cap | −20.78% |
| GENI.L | GENinCode Plc | $9.25M | Micro cap | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | $8.78M | Micro cap | −88.08% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | $8.66M | Micro cap | +7.14% |
| VRCI.L | Verici Dx plc | $6.99M | Micro cap | −57.14% |
| OBD.L | Oxford BioDynamics Plc | $6.85M | Micro cap | −74.11% |
| CNSL.L | Cambridge Nutritional Sciences plc | $6.14M | Micro cap | −41.54% |
| ALPRE.PA | Predilife S.A. | $5.10M | Micro cap | −65.74% |
| 2CUREX.ST | 2cureX AB (publ) | $1.34M | Micro cap | −71.79% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.